Table 1 Sociodemographic and clinical characteristics at baseline.
Patients (n = 967) | |
|---|---|
Sex, nº (%) | |
Male | 685 (71) |
Female | 282 (29) |
Age groups, nº (%) | |
< 25 | 35 (4) |
25 - <40 | 353 (36) |
40 - <60 | 518 (54) |
≥ 60 | 61 (6) |
Duration of OAT treatment in years, mean (SD) | 8 (6) |
Sociodemographic variables, nº (%) | |
10 years of education or less | 475 (49) |
Not formal paid work | 929 (96) |
Stable housinga | 845 (87) |
Living alone | 632 (65) |
Having children | 507 (53) |
Having children < 18 years | 209 (46) |
Injected drugs last 30 days | 306 (42) |
Current OAT medication, nº (%) | |
Methadone | 310 (32) |
Buprenorphine | 515 (53) |
Other | 142 (15) |
Non-prescribed substance use during the past 30 days, nº (%) b | |
Alcohol | 498 (55) |
Benzodiazepines | 484 (53) |
Cannabis | 579 (64) |
Opioids | 257 (28) |
Stimulantsc | 377 2) |